BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$367M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$354M |
| 3 |
Apple
AAPL
|
+$151M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$136M |
| 5 |
Alibaba
BABA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$170M |
| 2 |
Amazon
AMZN
|
+$167M |
| 3 |
JPMorgan Chase
JPM
|
+$142M |
| 4 |
Microsoft
MSFT
|
+$142M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.35% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 6.82% |
| 4 | Communication Services | 6.47% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEGI
2251
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $51.5K | ﹤0.01% |
+2,241
| New | +$46.5K |
|
|
CYS
2252
DELISTED
CYS Investments Inc.
CYS
| $51.4K | ﹤0.01% |
+6,143
| New | +$50.5K |
|
|
ARIA
2253
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $51.4K | ﹤0.01% |
+6,954
| New | +$52.2K |
|
|
SUM
2254
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $50.6K | ﹤0.01% |
+2,580
| New | +$51.5K |
|
|
CLD
2255
DELISTED
Cloud Peak Energy Inc
CLD
| $50.4K | ﹤0.01% |
24,470
+5,569
| +29% | +$11.4K |
|
|
ESIO
2256
DELISTED
Electro Scientific Industries
ESIO
| $50.2K | ﹤0.01% |
8,598
+4,079
| +90% | +$27.9K |
|
|
KG
2257
Kestrel Group
KG
$61M
| $49.5K | ﹤0.01% |
202
+160
| +381% | +$40.6K |
|
2258
TherapeuticsMD
TXMD
$24.1M
| $49.4K | ﹤0.01% |
+116
| New | +$47.8K |
|
2259
First Merchants
FRME
$2.75B
| $49.3K | ﹤0.01% |
1,977
+1,964
| +15,108% | +$48.8K |
|
2260
Agilysys
AGYS
$3.21B
| $49.2K | ﹤0.01% |
4,695
+2,111
| +82% | +$22.8K |
|
|
AVX
2261
DELISTED
AVX Corporation
AVX
| $48.8K | ﹤0.01% |
3,595
+2,742
| +321% | +$36.1K |
|
|
YDKN
2262
DELISTED
Yadkin Financial Corporation
YDKN
| $48.8K | ﹤0.01% |
+1,945
| New | +$48.7K |
|
2263
Pacira BioSciences
PCRX
$915M
| $48.7K | ﹤0.01% |
1,444
+1,417
| +5,248% | +$69.6K |
|
2264
Park National Corp
PRK
$3.75B
| $48.6K | ﹤0.01% |
+530
| New | +$48.2K |
|
|
BELFB
2265
Bel Fuse Inc Class B
BELFB
$4.17B
| $48.2K | ﹤0.01% |
2,713
+1,117
| +70% | +$18.9K |
|
2266
Wayfair
W
$13.9B
| $48.2K | ﹤0.01% |
+1,235
| New | +$49.3K |
|
|
EXAS
2267
DELISTED
Exact Sciences
EXAS
| $47.9K | ﹤0.01% |
3,910
+3,204
| +454% | +$24.1K |
|
2268
Primoris Services
PRIM
$4.48B
| $47.8K | ﹤0.01% |
2,523
+2,342
| +1,294% | +$50.6K |
|
|
GIMO
2269
DELISTED
Gigamon Inc.
GIMO
| $47.4K | ﹤0.01% |
+1,268
| New | +$40.4K |
|
|
UN
2270
DELISTED
Unilever NV New York Registry Shares
UN
| $47.4K | ﹤0.01% |
1,009
| – | – |
|
2271
Evertec
EVTC
$1.89B
| $47.3K | ﹤0.01% |
+3,041
| New | +$44K |
|
|
BSFT
2272
DELISTED
BroadSoft, Inc.
BSFT
| $46.9K | ﹤0.01% |
+1,144
| New | +$47.2K |
|
|
RP
2273
DELISTED
RealPage, Inc.
RP
| $46.7K | ﹤0.01% |
+2,093
| New | +$45.3K |
|
|
MSGN
2274
DELISTED
MSG Networks Inc.
MSGN
| $46.2K | ﹤0.01% |
3,009
+2,751
| +1,066% | +$46.3K |
|
|
PTLA
2275
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $46.1K | ﹤0.01% |
1,954
+1,914
| +4,785% | +$47.3K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2016 Portfolio in Review
As of Q2 2016, BNP Paribas Financial Markets held 3,650 positions worth $22.2B, down 6.2% from $23.6B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
BNP Paribas Financial Markets withdrew a net $1.98B in Q2 2016, closing 87 positions and reducing 780 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $34.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares Expanded Tech-Software Sector ETF worth $31.6M.
- BNP Paribas Financial Markets's largest Q2 2016 buy was iShares Expanded Tech-Software Sector ETF: 1,500,000 shares worth $31.6M.
- BNP Paribas Financial Markets added most to SPDR Gold Trust in Q2 2016, an estimated $367M increase.
- BNP Paribas Financial Markets's biggest Q2 2016 reduction was Berkshire Hathaway Class B, cutting an estimated $170M.
- BNP Paribas Financial Markets fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $34.9M.
- BNP Paribas Financial Markets's ten largest holdings make up 36% of its $22.2B portfolio in Q2 2016.
- BNP Paribas Financial Markets opened 978 new positions and closed 87 in Q2 2016.
- BNP Paribas Financial Markets's portfolio value fell 6.2% quarter-over-quarter to $22.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2016, filed 6 Jul 2016.